Search research articles
Contact Us
Filters
Showing results (301-310 of 688) with videos related to
Page
of 69
Sort By:
Metallomics : Integrated Biometal Science
|
February 24, 2011
The potential application of iron chelators for the treatment of neurodegenerative diseases
Robert C Hider, Sourav Roy, Yong Min Ma, et al.
Acta Haematologica
|
January 1, 1996
Design of orally active iron chelators
R C Hider, R Choudhury, B L Rai, et al.
The Journal of Rheumatology
|
January 5, 2005
Defining response to disease modifying antirheumatic drugs in patients with rheumatoid arthritis
Samantha L Hider, Ian N Bruce, Alan J Silman, et al.
Annals of Family Medicine
|
November 15, 2017
Factors Influencing Allopurinol Initiation in Primary Care
Lorna E Clarson, Samantha L Hider, John Belcher, et al.
Fertility and Sterility
|
June 6, 2007
Lupus anticoagulant and antibodies to beta 2-glycoprotein I, annexin V, and cardiolipin as a cause of recurrent spontaneous abortion
N Mtiraoui, W Zammiti, M Fekih, et al.
Expert Opinion on Drug Discovery
|
March 16, 2013
Plants of Indian origin in drug discovery
Pulok K Mukherjee, Sujay Rai, V Kumar, et al.
Antioxidants (Basel, Switzerland)
|
April 28, 2023
Studies on the Effect of Oxidation on Bioactivity of Phenolics and Wine Lees Extracts
Zhijing Ye, Jinlin Shi, Roland Harrison, et al.
International Journal of Antimicrobial Agents
|
September 21, 2021
Effect of iron chelation on anti-pseudomonal activity of doxycycline
M E Faure, A Cilibrizzi, V Abbate, et al.
Biochemical Pharmacology
|
February 15, 2001
Structure-activity investigation of the inhibition of 3-hydroxypyridin-4-ones on mammalian tyrosine hydroxylase
Z D Liu, M Lockwood, S Rose, et al.
FEMS Microbiology Letters
|
December 1, 2010
In vitro inhibition of bacterial growth by iron chelators
Di-Hong Qiu, Zhu-Liang Huang, Tao Zhou, et al.
Page
of 69
Search research articles
Search
Showing results (301-310 of 688) with videos related to
Sort By:
Page
of 69
Metallomics : Integrated Biometal Science
|
February 24, 2011
The potential application of iron chelators for the treatment of neurodegenerative diseases
Robert C Hider, Sourav Roy, Yong Min Ma, et al.
Acta Haematologica
|
January 1, 1996
Design of orally active iron chelators
R C Hider, R Choudhury, B L Rai, et al.
The Journal of Rheumatology
|
January 5, 2005
Defining response to disease modifying antirheumatic drugs in patients with rheumatoid arthritis
Samantha L Hider, Ian N Bruce, Alan J Silman, et al.
Annals of Family Medicine
|
November 15, 2017
Factors Influencing Allopurinol Initiation in Primary Care
Lorna E Clarson, Samantha L Hider, John Belcher, et al.
Fertility and Sterility
|
June 6, 2007
Lupus anticoagulant and antibodies to beta 2-glycoprotein I, annexin V, and cardiolipin as a cause of recurrent spontaneous abortion
N Mtiraoui, W Zammiti, M Fekih, et al.
Expert Opinion on Drug Discovery
|
March 16, 2013
Plants of Indian origin in drug discovery
Pulok K Mukherjee, Sujay Rai, V Kumar, et al.
Antioxidants (Basel, Switzerland)
|
April 28, 2023
Studies on the Effect of Oxidation on Bioactivity of Phenolics and Wine Lees Extracts
Zhijing Ye, Jinlin Shi, Roland Harrison, et al.
International Journal of Antimicrobial Agents
|
September 21, 2021
Effect of iron chelation on anti-pseudomonal activity of doxycycline
M E Faure, A Cilibrizzi, V Abbate, et al.
Biochemical Pharmacology
|
February 15, 2001
Structure-activity investigation of the inhibition of 3-hydroxypyridin-4-ones on mammalian tyrosine hydroxylase
Z D Liu, M Lockwood, S Rose, et al.
FEMS Microbiology Letters
|
December 1, 2010
In vitro inhibition of bacterial growth by iron chelators
Di-Hong Qiu, Zhu-Liang Huang, Tao Zhou, et al.
Page
of 69